Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
Bonifaz
A
A
Paredes
V
V
Fierro
L
L
D000284:Administration, Oral; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000627:therapeutic use; D009263:Nails, Ingrown / Q000139:chemically induced*; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D014009:Onychomycosis / Q000188:drug therapy* / Q000382:microbiology; D012189:Retrospective Studies; D000077291:Terbinafine; D016896:Treatment Outcome
D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D015725:Fluconazole; D000077291:Terbinafine